Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Nash

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Otolaryngology|January 31, 2025
Baseline disease characteristics by surgery history among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the global AROMA registryShigeharu Fujieda, Jayant M Pinto, David W Jang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2024
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment ComparisonClaire Hopkins, Joseph K Han, Wytske Fokkens, et al.
Journal of Asthma and Allergy|May 13, 2022
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNPClaus Bachert, Asif H Khan, Claire Hopkins, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
International Forum of Allergy & Rhinology|December 31, 2021
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trialsClaus Bachert, Jonathan Corren, Stella E Lee, et al.
Journal of Asthma and Allergy|June 30, 2025
Comparing Baseline Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps with and without Asthma in the AROMA RegistryAnju T Peters, Enrico Heffler, Kathleen M Buchheit, et al.
Advances in Therapy|April 30, 2026
Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID RegistryAnju T Peters, Andréanne Côté, Xavier Muñoz, et al.
International Archives of Allergy and Immunology|September 25, 2025
Prevalence of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA RegistryMartin Desrosiers, Tanya M Laidlaw, Andrew A White, et al.
International Forum of Allergy & Rhinology|August 7, 2023
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52Claus Bachert, Asif H Khan, Stella E Lee, et al.
Journal of Asthma and Allergy|June 14, 2022
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST StudyClaire Hopkins, Kathleen M Buchheit, Enrico Heffler, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Otolaryngology|January 31, 2025
Baseline disease characteristics by surgery history among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the global AROMA registryShigeharu Fujieda, Jayant M Pinto, David W Jang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2024
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment ComparisonClaire Hopkins, Joseph K Han, Wytske Fokkens, et al.
Journal of Asthma and Allergy|May 13, 2022
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNPClaus Bachert, Asif H Khan, Claire Hopkins, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
International Forum of Allergy & Rhinology|December 31, 2021
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trialsClaus Bachert, Jonathan Corren, Stella E Lee, et al.
Journal of Asthma and Allergy|June 30, 2025
Comparing Baseline Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps with and without Asthma in the AROMA RegistryAnju T Peters, Enrico Heffler, Kathleen M Buchheit, et al.
Advances in Therapy|April 30, 2026
Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID RegistryAnju T Peters, Andréanne Côté, Xavier Muñoz, et al.
International Archives of Allergy and Immunology|September 25, 2025
Prevalence of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA RegistryMartin Desrosiers, Tanya M Laidlaw, Andrew A White, et al.
International Forum of Allergy & Rhinology|August 7, 2023
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52Claus Bachert, Asif H Khan, Stella E Lee, et al.
Journal of Asthma and Allergy|June 14, 2022
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST StudyClaire Hopkins, Kathleen M Buchheit, Enrico Heffler, et al.
Pageof 5